| Original language | English |
|---|---|
| Pages (from-to) | e49-e52 |
| Journal | British Journal of Haematology |
| Volume | 197 |
| Issue number | 4 |
| DOIs | |
| State | Published - May 2022 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: British Journal of Haematology, Vol. 197, No. 4, 05.2022, p. e49-e52.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib
AU - Zhou, Amy
AU - Kong, Tim
AU - Fowles, Jared S.
AU - Jung, Chun Ling
AU - Allen, Maggie J.
AU - Fisher, Daniel A.C.
AU - Fulbright, Mary
AU - Nemeth, Elizabeta
AU - Ganz, Tomas
AU - Oh, Stephen T.
N1 - Funding Information: This work was supported by NIH grants R01HL134952 (Stephen T. Oh) and T32HL007088 (Jared S. Fowles). Support for patient sample collection and processing was provided by NIH grant P01CA101937. CRP and Iron studies were run by the Core Laboratory for Clinical Studies (CLCS) at Washington University in St. Louis which is supported in part by the Washington University Diabetes Research and Training Centre (DRTC) and the Washington University Institute of Clinical and Translational Sciences (ICTS). Technical support was provided by the Alvin J. Siteman Cancer Centre Tissue Procurement Core Facility and Immunomonitoring Laboratory, which are supported by NCI Cancer Centre Support Grant P30CA91842. The Immunomonitoring Laboratory is also supported by the Andrew M and Jane M Bursky Centre for Human Immunology and Immunotherapy Programs. The authors thank D. Bender for assistance with multiplex cytokine measurement.
PY - 2022/5
Y1 - 2022/5
UR - https://www.scopus.com/pages/publications/85124481137
U2 - 10.1111/bjh.18044
DO - 10.1111/bjh.18044
M3 - Letter
C2 - 35128632
AN - SCOPUS:85124481137
SN - 0007-1048
VL - 197
SP - e49-e52
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 4
ER -